These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 35179953)

  • 21. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncGBP9/miR-34a axis drives macrophages toward a phenotype conducive for spinal cord injury repair via STAT1/STAT6 and SOCS3.
    Zhou J; Li Z; Wu T; Zhao Q; Zhao Q; Cao Y
    J Neuroinflammation; 2020 Apr; 17(1):134. PubMed ID: 32345320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin Reprograms TAMs from a Protumor Phenotype towards an Antitumor Phenotype via Inhibiting MAO-A/STAT6 Pathway.
    Jiang M; Qi Y; Huang W; Lin Y; Li B
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8
    Zhu CX; Yan K; Chen L; Huang RR; Bian ZH; Wei HR; Gu XM; Zhao YY; Liu MC; Suo CX; Li ZK; Yang ZY; Lu MQ; Hua XF; Li L; Zhao ZB; Sun LC; Zhang HF; Gao P; Lian ZX
    J Hepatol; 2024 Oct; 81(4):690-703. PubMed ID: 38759889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nocardia rubra cell wall skeleton regulates tumour-associated macrophage polarization by reprogramming M2 macrophages into M1 macrophages via STAT1/STAT6 pathways.
    Chen W; Guo Q; Zhang Y; Liu Q; Zhang Y; Zhao C; Li X; Bai X; Zhang L; Shao S
    Scand J Immunol; 2023 Dec; 98(6):e13320. PubMed ID: 38441254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Garcinone E suppresses breast cancer growth and metastasis by modulating tumor-associated macrophages polarization via STAT6 signaling.
    Nie X; Fu L; Cheng Y; Wu X; Lv K; Li R; Wu Y; Leung GP; Fu C; Lee SM; Seto SW; Zhang J; Li J
    Phytother Res; 2023 Oct; 37(10):4442-4456. PubMed ID: 37259475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
    Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
    Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy.
    Li SL; Hou HY; Chu X; Zhu YY; Zhang YJ; Duan MD; Liu J; Liu Y
    ACS Nano; 2024 Mar; 18(11):7769-7795. PubMed ID: 38420949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer.
    Kim H; Park HJ; Chang HW; Back JH; Lee SJ; Park YE; Kim EH; Hong Y; Kwak G; Kwon IC; Lee JE; Lee YS; Kim SY; Yang Y; Kim SH
    Bioact Mater; 2023 Jul; 25():527-540. PubMed ID: 37056267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24.
    Yu T; Gan S; Zhu Q; Dai D; Li N; Wang H; Chen X; Hou D; Wang Y; Pan Q; Xu J; Zhang X; Liu J; Pei S; Peng C; Wu P; Romano S; Mao C; Huang M; Zhu X; Shen K; Qin J; Xiao Y
    Nat Commun; 2019 Sep; 10(1):4353. PubMed ID: 31554795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomal ncRNAs facilitate interactive 'dialogue' between tumor cells and tumor-associated macrophages.
    Zhou X; Liu Q; Wang X; Yao X; Zhang B; Wu J; Sun C
    Cancer Lett; 2023 Jan; 552():215975. PubMed ID: 36306940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.
    Moradi-Chaleshtori M; Bandehpour M; Heidari N; Mohammadi-Yeganeh S; Mahmoud Hashemi S
    Int Immunopharmacol; 2021 Jan; 90():107198. PubMed ID: 33249048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response.
    Wang YN; Wang YY; Wang J; Bai WJ; Miao NJ; Wang J
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37652576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy.
    Zhang W; Liu X; Cao S; Zhang Q; Chen X; Luo W; Tan J; Xu X; Tian J; Saw PE; Luo B
    ACS Nano; 2023 Aug; 17(15):14424-14441. PubMed ID: 37498878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression.
    Osorio EY; Zhao W; Espitia C; Saldarriaga O; Hawel L; Byus CV; Travi BL; Melby PC
    PLoS Pathog; 2012 Jan; 8(1):e1002417. PubMed ID: 22275864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of tumor-associated macrophages in lung cancer: From mechanism to small molecule therapy.
    Zhou Y; Qian M; Li J; Ruan L; Wang Y; Cai C; Gu S; Zhao X
    Biomed Pharmacother; 2024 Jan; 170():116014. PubMed ID: 38134634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulation of Tumor Microenvironment by Arginine-Loaded Iron Oxide Nanoparticles for Gaseous Immunotherapy.
    Wu X; Cheng Y; Zheng R; Xu K; Yan J; Song P; Wang Y; Rauf A; Pan Y; Zhang H
    ACS Appl Mater Interfaces; 2021 May; 13(17):19825-19835. PubMed ID: 33881837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.